Home/Events/Citrini and Anthropic's Experiment with Claude on Scorpion Antivenom

Citrini and Anthropic's Experiment with Claude on Scorpion Antivenom

Developing
Confidence
70%
Impact: 50%
Updated 4m ago

Consensus Brief

Citrini Research collaborated with Anthropic to explore the potential of the AI model Claude in drug development, specifically for scorpion antivenom. While Claude generated a number of protein designs that could bind to scorpion toxins, experts noted that the experiment did not produce a viable drug candidate, highlighting the challenges in translating such findings into effective treatments.

Sourced from
Primary: The Verge

What Changed Since Last Update

4m ago

New corroborating source added: The Verge published an update on 2026-10-22 ("Claude did not invent scorpion antivenom").

Claim Ledger

4 claims tracked across sources

Confirmed Fact

Claude generated nearly 320,000 candidates, whittling them down to 180 designs.

Confirmed Fact

Seventeen of the proteins passed muster, collectively binding to four of the five scorpion toxins.

Confirmed Fact

Citrini acknowledged that no experiment has yet tested whether they actually stopped the toxin working.

Independent Finding

Experts described the findings as far from a medicine and hyped.

Role-Based Impact Analysis